Durvalumab vs Tamsulosin

Durvalumab vs Tamsulosin: Overview

This comparison examines the pharmacological differences between Durvalumab and Tamsulosin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Tamsulosin: Selective alpha-1A adrenergic receptor antagonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Tamsulosin — 10-13 hours.

Chemical Properties

Molecular Formula: Tamsulosin — C20H28N2O5S.

Molecular Weight: Tamsulosin — 408.5100 g/mol.

Type: Durvalumab — Antibody; Tamsulosin — Small molecule.